Volume 23, Number 1—January 2017
Dispatch
Acute Respiratory Disease in US Army Trainees 3 Years after Reintroduction of Adenovirus Vaccine1
Nakia S. Clemmons2
, Zachary D. McCormic, Joel C. Gaydos, Anthony W. Hawksworth, and Nikki N. Jordan
, Zachary D. McCormic, Joel C. Gaydos, Anthony W. Hawksworth, and Nikki N. Jordan
Table
Rate of ARD cases and percent change by year at 4 US Army initial entry training sites, 2010–2014*
| Year | Average ARD rate (% change), by training site† |
Overall† | |||
|---|---|---|---|---|---|
| Fort Benning | Fort Jackson | Fort Sill | Fort Leonard Wood | ||
| 2010 | 0.29 | 0.67 | 0.20 | 0.43 | 0.43 |
| 2011 | 0.18 (−38) | 0.44 (−34) | 0.75 (+275) | 0.35 (−19) | 0.39 (−9) |
| 2012 | 0.06 (−79) | 0.08 (−88) | 0.19 (−5) | 0.08 (−81) | 0.09 (−79) |
| 2013 | 0.06 (−79) | 0.09 (−87) | 0.13 (−35) | 0.08 (−81) | 0.08 (−81) |
| 2014 | 0.04 (−86) | 0.07 (−90) | 0.08 (−60) | 0.05 (−88) | 0.06 (−86) |
*The adenovirus vaccine program was reintroduced in November 2011 and rate changes were studied through 2014. ARD, acute respiratory disease.
†ARD rate = (ARD cases/all trainees) × 100 trainee weeks. % change calculated from last full year before vaccination (i.e., 2010).
1Preliminary results from this study were presented at the IDWeek 2014 meeting, October 8–12, 2014; Philadelphia, Pennsylvania, USA.
2Current affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Page created: December 14, 2016
Page updated: December 14, 2016
Page reviewed: December 14, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.